biote Corp. (BTMD)

NASDAQ: BTMD · USD

$1.15

-0.03 (-2.5%)· Recorded snapshot

Market cap	39M
Revenue (ttm)	183.5M
Net income (ttm)	5.9M
EPS (ttm)	$0.18
Shares out	33.9M
P/E (trailing)	6.3x
P/E (forward)	39.3x
Volume	69,134
Beta	1.69

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 183.5M
Net income (ttm): 5.9M
EPS (ttm): $0.18
P/E (trailing): 6.3x
P/E (forward): 39.3x
Market cap: 39M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E39.3

P25 n/aP50 n/aP75 n/a

Trailing P/E6.3

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC23.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BTMD indicators

Market & fundamental data

Available fields

241

Groups with data

Currency

USD

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001819253
Company name	biote Corp.
Country	United States
Country code	US
CUSIP number	090683103
Earnings date	2026-11-04
Earnings time	amc
Employees	223
Employees change	6
Employees growth	2.76%
Enterprise value	$156.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2012
Industry	Medical Care Facilities
Is primary listing	Yes
Is SPAC	No
ISIN number	US0906831039
Last 10-K release date	2026-03-13
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$39M
Market cap category	Nano-Cap
Next earnings date	2026-11-04
Options	No
Price	$1.15
Price currency	USD
Sector	Healthcare
SIC code	2833
Stock price date	2026-10-28
Symbol	BTMD
U.S. state	Texas
Website	https://www.biote.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	3.18x
Average P/E ratio (3Y)	22.95x
Average P/E ratio (5Y)	19.1x
Earnings yield	15.77%
EV/Earnings	26.89x
EV/EBIT	6.96x
EV/EBITDA	6.18x
EV/FCF	7.92x
EV/Sales	0.86x
FCF / EV yield	12.62%
FCF yield	49.68%
Forward EV/Sales	0.88x
Forward P/E	39.33x
Forward P/S	0.22x
Industry forward P/E	14.81x
Industry P/E	18.21x
Lynch fair value	$0.91
Lynch upside	-23.17%
P/(FCF - SBC) ratio	3.47x
P/(OCF - SBC) ratio	2.5x
P/E ratio	6.34x
P/FCF ratio	2.01x
P/OCF ratio	1.64x
P/S ratio	0.22x
Price/EBITDA ratio	1.57x
Sector forward P/E	23.53x
Sector P/E	51.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	12.33%
EBITDA margin	13.89%
Effective tax rate	30.98%
FCF margin	10.83%
Gross margin	69.45%
Operating margin	12.33%
Pretax margin	5.59%
Profit margin	3.19%
Profit per employee	$26,260
Profitable years	3
Revenue per employee	$823,009
ROA	13.7%
ROA (5Y)	15.54%
ROCE	31.62%
ROIC	23.6%
ROIC (5Y)	44.61%
SBC / revenue	4.54%
Tax / revenue	1.73%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-79.39%
EPS growth 5Y	-63.95%
EPS growth years	1
FCF growth	-42.93%
FCF growth 3Y	-14.81%
FCF growth 5Y	-5.33%
Gross profit growth	-11.03%
Gross profit growth (Q)	-15.63%
Gross profit growth 3Y	1.45%
Gross profit growth 5Y	12.21%
Net income growth	-81.3%
Net income growth 5Y	-27.46%
Net income growth years	1
OCF growth	-41.25%
OCF growth 3Y	-8.88%
OCF growth 5Y	-1.61%
Operating income growth	-46.42%
Operating income growth (Q)	-79.77%
Operating income growth 3Y	-18.96%
Operating income growth 5Y	-6.56%
Revenue growth	-7.81%
Revenue growth (Q)	-9.48%
Revenue growth (QoQ)	-1.56%
Revenue growth 3Y	0.55%
Revenue growth 5Y	9.5%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-4.5M
Depreciation and amortization	$2.8M
EBIT	$22.6M
EBITDA	$25.5M
EPS	$0.18
FCF per share	$0.59
Financing cash flow	$-26M
Free cash flow	$19.9M
Free cash flow minus SBC	$11.5M
Gross profit	$127.5M
Income taxes	$3.2M
Investing cash flow	$-6.8M
Net borrowing	$89.3M
Net cash flow	$-8.4M
Net income	$5.9M
Operating cash flow minus SBC	$16M
Operating income	$22.6M
Revenue	$183.5M
Stock-based compensation	$8.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.3
Book value per share	$-2.38
Debt / EBITDA	4.88
Debt / FCF	6.47
Goodwill	$5.8M
Interest coverage	2.42
Long-term assets	$58.7M
Long-term liabilities	$129.8M
Net cash (debt)	$-117.5M
Net cash / market cap	-293.67%
Net debt / EBITDA	4.61
Net debt / FCF	5.91
Piotroski F-Score	5
Property, plant and equipment	$19.7M
Shareholders' equity	$-58.2M
Tangible book value	$-80.2M
Tangible book value per share	$-2.90
Total assets	$101.7M
Total cash	$11.2M
Total debt	$128.6M
Total liabilities	$159.9M
WACC	7.04%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.78
Current assets	$43M
Current liabilities	$30.1M
Current ratio	1.43
Inventory turnover	3.22
Net working capital	$5.6M
Quick ratio	0.69
Working capital	$12.9M
Working capital turnover	30.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	7.45%
Dividend yield	0%
Shareholder yield	7.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$1.79
1D price change	-2.54%
1M price change	-3.28%
1M total return	-3.28%
1W price change	10.28%
1W total return	10.28%
1Y price change	-59.31%
1Y return CAGR	-59.34%
1Y total return	-59.31%
20-day SMA	$1.12
200-day SMA	$1.84
3M price change	-49.36%
3M total return	-49.36%
3Y price change	-76.91%
3Y return CAGR	-38.64%
3Y total return	-76.91%
50-day SMA	$1.31
50-day SMA vs 200-day SMA	50under200
52-week high	$2.98
52-week high date	2025-11-06
52-week low	$1.00
52-week low date	2026-10-13
5Y price change	-87.9%
5Y return CAGR	-34.45%
5Y total return	-87.9%
6M price change	-48.02%
6M total return	-48.02%
All-time high	$10.53
All-time high date	2022-05-24
All-time low	$1.00
All-time low date	2026-10-13
Average true range (ATR)	$0.10
Average volume	109.9K
Beta (1Y)	1.93
Beta (2Y)	1.36
Beta (5Y)	1.69
Change from 52-week high	-61.41%
Change from 52-week low	15%
Change from all-time high	-88.79%
Change from all-time low	18%
Change from open	-4.17%
Day's gap	1.69%
Dollar volume	$79,504
High price	$1.20
Low price	$1.15
Monthly RSI	33.35
Open price	$1.20
Position in 52-week range	0%
Premarket change	-2.53%
Premarket close	$1.18
Premarket price	$1.15
Premarket volume	20K
Previous close	$1.18
Price vs 150-day SMA	-35.72%
Price vs 20-day SMA	3.05%
Price vs 200-day SMA	-37.53%
Price vs 50-day SMA	-11.94%
Relative volume	0.63
RSI	49.65
Sharpe ratio	-0.87
Sharpe ratio (3Y)	-0.34
Sharpe ratio (5Y)	-0.28
Sortino ratio	-1.09
Sortino ratio (3Y)	-0.4
Sortino ratio (5Y)	-0.31
Volume	69.1K
Weekly RSI	37.11
YTD price change	-54.62%
YTD total return	-54.62%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	16.5M
Float percentage	48.56%
Shares change (QoQ)	-20.47%
Shares change (YoY)	-7.45%
Shares held by insiders	19.43%
Shares held by institutions	39.12%
Shares outstanding	33.9M
Short % of float	6.58%
Short % of shares	3.2%
Short ratio	6 days

Deeper analysis on BTMD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BTMD report

Is a complete BTMD research report available?

No complete published report is available for biote Corp. (BTMD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

biote Corp. (BTMD)

Price

Financial snapshot

Fair-value bridge

Latest news · BTMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BTMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BTMD

Frequently asked questions